GeoVax Labs, Inc.
- GOVX
- NASDAQ
- Biotechnology
- Vaccine Development
- Immunotherapy
- MVA-VLP Platform
$0.23
Today −1.93%Quote Oct 19, 2026, 06:24 PM UTC
−37.78%over the last month
Max drawdown −37.8%From 1-month high −37.8%3 months −75.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About GeoVax Labs
GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
19
Founded
1988
Market value
$1.7M
Quote Oct 19
Analyst target
$100.00
+42689.9% from here
Floor
$0.21
8.3% below price
Resistance
$0.34
44.3% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GOVXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free